Cytotoxicity mediation of cells evidencing surface expression of CD44

Details for Australian Patent Application No. 2004266045 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Findlay, Helen P.; Young, David S. F.; Hahn, Susan E.

Agent Davies Collison Cave

Pub. Number AU-B-2004266045

PCT Pub. Number WO2005/018667

Priority 10/647,818 22.08.03 US

Parent 2004248865

Filing date 20 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 17 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 49/00 (2006.01) Preparations for testing

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/018667 Priority application(s): WO2005/018667

21 May 2009 Assignment before Grant

  Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG

17 March 2011 Application Accepted

  Published as AU-B-2004266045

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266047-pH colour indicator for use with agricultural compounds

2004266044-Photodynamic therapy